Takayama; Kiyoshi

Patent Applications and Registrations

Patent applications and USPTO patent grants for Takayama; Kiyoshi.The latest application filed is for "method for selecting cells, method for producing nucleic acid, method for producing recombinant cells, method for producing target substance, method for producing pharmaceutical composition, and reagent".

Company Profile

2.14.17

Takayama; Kiyoshi - Sapporo JP
TAKAYAMA; Kiyoshi - Sapporo-shi Hokkaido
Takayama; Kiyoshi - Hokkaido JP
Takayama; Kiyoshi - Moriguchi-shi JP
Takayama; Kiyoshi - Toshima-ku JP
Takayama; Kiyoshi - Tokyo JP

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Method for selecting cells, method for producing nucleic acid, method for producing recombinant cells, method for producing target substance, method for producing pharmaceutical composition, and reagent Grant 11,357,787 - Ashida , et al. June 14, 2	2022-06-14
Method For Selecting Cells, Method For Producing Nucleic Acid, Method For Producing Recombinant Cells, Method For Producing Target Substance, Method For Producing Pharmaceutical Composition, And Reagent App 20220040216 - ASHIDA; Masami ; et al.	2022-02-10
Antibody Against Human Prostaglandin E2 Receptor Ep4 App 20190389949 - Takayama; Kiyoshi ; et al.	2019-12-26
Antibody against human prostaglandin E2 receptor EP4 Grant 10,435,465 - Takayama , et al. O	2019-10-08
Anti-human CCR7 antibody, hybridoma, nucleic acid, vector, cell, pharmaceutical composition, and antibody-immobilized carrier Grant 9,505,844 - Nishiguchi , et al. November 29, 2	2016-11-29
Antibody Against Human Prostaglandin E2 Receptor Ep4 App 20160075780 - Takayama; Kiyoshi ; et al.	2016-03-17
Antibody against human prostaglandin E.sub.2 receptor EP4 Grant 9,175,080 - Takayama , et al. November 3, 2	2015-11-03
Inhibitor of casein kinase 1.delta. and casein kinase 1.epsilon. Grant 9,018,238 - Okamoto , et al. April 28, 2	2015-04-28
Anti-human Ccr7 Antibody, Hybridoma, Nucleic Acid, Vector, Cell, Pharmaceutical Composition, And Antibody-immobilized Carrier App 20150017167 - NISHIGUCHI; Naoki ; et al.	2015-01-15
Anti-human Ccr7 Antibody, Hybridoma, Nucleic Acid, Vector, Cell, Pharmaceutical Composition, And Antibody-immobilized Carrier App 20150010998 - NISHIGUCHI; Naoki ; et al.	2015-01-08
Anti-human CCR7 antibody, hybridoma, nucleic acid, vector, cell, pharmaceutical composition, and antibody-immobilized carrier Grant 8,865,170 - Nishiguchi , et al. October 21, 2	2014-10-21
Inhibitor of casein kinase 1delta and casein kinase 1E Grant 8,710,231 - Okamoto , et al. April 29, 2	2014-04-29
Antibody Against Human Prostaglandin E2 Receptor Ep4 App 20130197199 - Takayama; Kiyoshi ; et al.	2013-08-01
Anti-human Ccr7 Antibody, Hybridoma, Nucleic Acid, Vector, Cell, Pharmaceutical Composition, And Antibody-immobilized Carrier App 20130195869 - Nishiguchi; Naoki ; et al.	2013-08-01
Inhibitor Of Casein Kinase 1delta And Casein Kinase 1e App 20130137730 - Okamoto; Masako ; et al.	2013-05-30
Method Of Regenerating Elastic Fiber And Screening Method App 20120196282 - NAKAMURA; Tomoyuki ; et al.	2012-08-02
Macrolide derivatives Grant 8,124,744 - Kashimura , et al. February 28, 2	2012-02-28
Inhibitor Of Casein Kinase 1delta And Casein Kinase 1epsilon App 20110294857 - Okamoto; Masako ; et al.	2011-12-01
Clarithromycin or salt thereof for use in the treatment or prevention of pulmonary disease induced by destruction of pulmonary alveoli Grant 8,017,588 - Takayama September 13, 2	2011-09-13
Clarithromycin Or Salt Thereof For Use In The Treatment Or Prevention Of Pulmonary Disease Induced By Destruction Of Pulmonary Alveoli App 20090088395 - Takayama; Kiyoshi	2009-04-02
Macrolide Derivatives App 20090076253 - Kashimura; Masato ; et al.	2009-03-19
Methods of identifying anti-inflammatory macrolides App 20070172957 - Fanton; Christie ; et al.	2007-07-26
Clarithromycin or a salt thereof for the treatment or prevention of pulmonary disorders caused by the destruction of pulmonary alveoli App 20060293261 - Takayama; Kiyoshi	2006-12-28
Method for screening compounds which modulate glucose transporting activity Grant 6,723,521 - Yoshimoto , et al. April 20, 2	2004-04-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.